Katharine Andress Rowe Price, Kevin Joseph Harrington, Francis P. Worden, Ricard Mesia, Caroline Even, David Schaaf, Sally Jones, Nabil F. Saba, Robert I. Haddad. "VERSATILE-003: A phase 3, randomized, open-label trial of PDS0101 and pembrolizumab compared with pembrolizumab for first-line treatment of patients with HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps6111